114 related articles for article (PubMed ID: 29482945)
1. Metformin influences drug sensitivity in pancreatic cancer cells.
Candido S; Abrams SL; Steelman L; Lertpiriyapong K; Martelli AM; Cocco L; Ratti S; Follo MY; Murata RM; Rosalen PL; Lombardi P; Montalto G; Cervello M; Gizak A; Rakus D; Suh PG; Libra M; McCubrey JA
Adv Biol Regul; 2018 May; 68():13-30. PubMed ID: 29482945
[TBL] [Abstract][Full Text] [Related]
2. Dose-Dependent AMPK-Dependent and Independent Mechanisms of Berberine and Metformin Inhibition of mTORC1, ERK, DNA Synthesis and Proliferation in Pancreatic Cancer Cells.
Ming M; Sinnett-Smith J; Wang J; Soares HP; Young SH; Eibl G; Rozengurt E
PLoS One; 2014; 9(12):e114573. PubMed ID: 25493642
[TBL] [Abstract][Full Text] [Related]
3. Metformin Restrains Pancreatic Duodenal Homeobox-1 (PDX-1) Function by Inhibiting ERK Signaling in Pancreatic Ductal Adenocarcinoma.
Zhou G; Yu J; Wang A; Liu SH; Sinnett-Smith J; Wu J; Sanchez R; Nemunaitis J; Ricordi C; Rozengurt E; Brunicardi FC
Curr Mol Med; 2016; 16(1):83-90. PubMed ID: 26695692
[TBL] [Abstract][Full Text] [Related]
4. Abilities of berberine and chemically modified berberines to interact with metformin and inhibit proliferation of pancreatic cancer cells.
Akula SM; Candido S; Libra M; Abrams SL; Steelman LS; Lertpiriyapong K; Ramazzotti G; Ratti S; Follo MY; Martelli AM; Murata RM; Rosalen PL; Bueno-Silva B; Matias de Alencar S; Montalto G; Cervello M; Gizak A; Rakus D; Mao W; Lin HL; Lombardi P; McCubrey JA
Adv Biol Regul; 2019 Aug; 73():100633. PubMed ID: 31047842
[TBL] [Abstract][Full Text] [Related]
5. Introduction of WT-TP53 into pancreatic cancer cells alters sensitivity to chemotherapeutic drugs, targeted therapeutics and nutraceuticals.
Abrams SL; Lertpiriyapong K; Yang LV; Martelli AM; Cocco L; Ratti S; Falasca M; Murata RM; Rosalen PL; Lombardi P; Libra M; Candido S; Montalto G; Cervello M; Steelman LS; McCubrey JA
Adv Biol Regul; 2018 Aug; 69():16-34. PubMed ID: 29980405
[TBL] [Abstract][Full Text] [Related]
6. Sensitivity of pancreatic cancer cells to chemotherapeutic drugs, signal transduction inhibitors and nutraceuticals can be regulated by WT-TP53.
Abrams SL; Akula SM; Martelli AM; Cocco L; Ratti S; Libra M; Candido S; Montalto G; Cervello M; Gizak A; Rakus D; Steelman LS; McCubrey JA
Adv Biol Regul; 2021 Jan; 79():100780. PubMed ID: 33451973
[TBL] [Abstract][Full Text] [Related]
7. Metformin Improves Survival in Patients with Pancreatic Ductal Adenocarcinoma and Pre-Existing Diabetes: A Propensity Score Analysis.
Amin S; Mhango G; Lin J; Aronson A; Wisnivesky J; Boffetta P; Lucas AL
Am J Gastroenterol; 2016 Sep; 111(9):1350-7. PubMed ID: 27430290
[TBL] [Abstract][Full Text] [Related]
8. Metformin disrupts crosstalk between G protein-coupled receptor and insulin receptor signaling systems and inhibits pancreatic cancer growth.
Kisfalvi K; Eibl G; Sinnett-Smith J; Rozengurt E
Cancer Res; 2009 Aug; 69(16):6539-45. PubMed ID: 19679549
[TBL] [Abstract][Full Text] [Related]
9. Crosstalk between insulin/insulin-like growth factor-1 receptors and G protein-coupled receptor signaling systems: a novel target for the antidiabetic drug metformin in pancreatic cancer.
Rozengurt E; Sinnett-Smith J; Kisfalvi K
Clin Cancer Res; 2010 May; 16(9):2505-11. PubMed ID: 20388847
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of Aurora Kinase A Induces Necroptosis in Pancreatic Carcinoma.
Xie Y; Zhu S; Zhong M; Yang M; Sun X; Liu J; Kroemer G; Lotze M; Zeh HJ; Kang R; Tang D
Gastroenterology; 2017 Nov; 153(5):1429-1443.e5. PubMed ID: 28764929
[TBL] [Abstract][Full Text] [Related]
11. Metformin suppresses the invasive ability of pancreatic cancer cells by blocking autocrine TGF‑β1 signaling.
Duan W; Qian W; Zhou C; Cao J; Qin T; Xiao Y; Cheng L; Li J; Chen K; Li X; Ma J; Ma Q
Oncol Rep; 2018 Sep; 40(3):1495-1502. PubMed ID: 29956804
[TBL] [Abstract][Full Text] [Related]
12. Metformin suppresses cancer initiation and progression in genetic mouse models of pancreatic cancer.
Chen K; Qian W; Jiang Z; Cheng L; Li J; Sun L; Zhou C; Gao L; Lei M; Yan B; Cao J; Duan W; Ma Q
Mol Cancer; 2017 Jul; 16(1):131. PubMed ID: 28738823
[TBL] [Abstract][Full Text] [Related]
13. Mitochondria-Targeted Analogues of Metformin Exhibit Enhanced Antiproliferative and Radiosensitizing Effects in Pancreatic Cancer Cells.
Cheng G; Zielonka J; Ouari O; Lopez M; McAllister D; Boyle K; Barrios CS; Weber JJ; Johnson BD; Hardy M; Dwinell MB; Kalyanaraman B
Cancer Res; 2016 Jul; 76(13):3904-15. PubMed ID: 27216187
[TBL] [Abstract][Full Text] [Related]
14. An observational study to justify and plan a future phase III randomized controlled trial of metformin in improving overall survival in patients with inoperable pancreatic cancer without liver metastases.
Broadhurst PJ; Hart AR
J Cancer Res Clin Oncol; 2020 May; 146(5):1369-1375. PubMed ID: 32157435
[TBL] [Abstract][Full Text] [Related]
15. Abilities of β-Estradiol to interact with chemotherapeutic drugs, signal transduction inhibitors and nutraceuticals and alter the proliferation of pancreatic cancer cells.
Akula SM; Candido S; Abrams SL; Steelman LS; Lertpiriyapong K; Cocco L; Ramazzotti G; Ratti S; Follo MY; Martelli AM; Murata RM; Rosalen PL; Bueno-Silva B; Matias de Alencar S; Falasca M; Montalto G; Cervello M; Notarbartolo M; Gizak A; Rakus D; Libra M; McCubrey JA
Adv Biol Regul; 2020 Jan; 75():100672. PubMed ID: 31685431
[TBL] [Abstract][Full Text] [Related]
16. Peroxisome proliferator activated receptors at the crossroad of obesity, diabetes, and pancreatic cancer.
Polvani S; Tarocchi M; Tempesti S; Bencini L; Galli A
World J Gastroenterol; 2016 Feb; 22(8):2441-59. PubMed ID: 26937133
[TBL] [Abstract][Full Text] [Related]
17. The therapeutic targeting of the FGFR1/Src/NF-κB signaling axis inhibits pancreatic ductal adenocarcinoma stemness and oncogenicity.
Lai SW; Bamodu OA; Tsai WC; Chang YM; Lee WH; Yeh CT; Chao TY
Clin Exp Metastasis; 2018 Oct; 35(7):663-677. PubMed ID: 29987671
[TBL] [Abstract][Full Text] [Related]
18. A Metabolic Inhibitory Cocktail for Grave Cancers: Metformin, Pioglitazone and Lithium Combination in Treatment of Pancreatic Cancer and Glioblastoma Multiforme.
Elmaci İ; Altinoz MA
Biochem Genet; 2016 Oct; 54(5):573-618. PubMed ID: 27377891
[TBL] [Abstract][Full Text] [Related]
19. Metformin and Rapamycin Reduce Pancreatic Cancer Growth in Obese Prediabetic Mice by Distinct MicroRNA-Regulated Mechanisms.
Cifarelli V; Lashinger LM; Devlin KL; Dunlap SM; Huang J; Kaaks R; Pollak MN; Hursting SD
Diabetes; 2015 May; 64(5):1632-42. PubMed ID: 25576058
[TBL] [Abstract][Full Text] [Related]
20. Metformin as an Adjunctive Therapy for Pancreatic Cancer: A Review of the Literature on Its Potential Therapeutic Use.
Broadhurst PJ; Hart AR
Dig Dis Sci; 2018 Nov; 63(11):2840-2852. PubMed ID: 30159732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
